ARNA Panacea (ARNA)

ARNA Genomics was established

Seed round; Development of ARNA-Thermometr, a test for the presence of oncological diseases; “Know-how” objects formalization

Development of ARNA Breast Cancer - a high-precision test for early detection of breast cancer

Development of ARNA Colon Cancer; ARNA BC development is completed; Beginning of laboratory tests of ARNA BC; Submission of patent application No 1

End of laboratory tests of ARNA BC; Start of ARNA BC clinical research jointly with Sechenov University; Submission of application of Patent Cooperation Treaty No 1; Token Distribution Event

- Opening of the office and the 1st laboratory unit in the USA.
- Submission of application of Patent Cooperation Treaty No 2 and 3.
- Agreement of the regulatory strategy for ARNA BC. Launch of clinical research No 1 in the USA with FDA.
- ARNA CC development is completed, starting laboratory research.
- ARNA Panacea – launch of the beta version of blockchain-ecosystem, basic documentation for develop

- Using of ARNA Panacea’s blockchain ecosystem by interested market players (regulators, investors, users, etc.)
- Start of development: ARNA Lung, ARNA Liver, ARNA Pancreas;
- ARNA BC’s entry into the US market;
- Clinical trials in China;
- National phases: USA, China, India, EU, UK, Israel, Brazil;
- Seed round B;
- Receiving the first revenue.